Base-Editing Gene Therapy Shows Promise in Sickle Cell Disease

(MedPage Today) — Treatment with the investigational base-editing gene therapy ristoglogene autogetemcel (risto-cel) showed promise in patients with sickle cell disease, according to an interim analysis of the phase I/II BEACON study.
Neutrophil…